Harold I. Daniel

Harold I. Daniel, MD, MSc, PhD, currently serves as the Regional Medical Director of Medical Affairs at Krystal Biotech, Inc., since January 2022. Previously, Daniel held the position of Regional Medical Director for US Medical Affairs at Novartis Gene Therapies from April 2018 to March 2022, where responsibilities included facilitating medical/scientific exchange with US stakeholders. Other roles include Senior Medical Science Liaison at Retrophin and Medical Science Liaison at Alimera Sciences, with earlier experience as Global Medical Evidence Lead at AstraZeneca, ensuring scientific evidence for brand claims. Additional positions in Medical Affairs were held at Sucampo Pharmaceuticals, ISTA Pharmaceuticals, Boehringer Ingelheim, and Novo Nordisk. Project management experience was gained at Howard University. Educational credentials include a Doctor of Medicine from Ahmadu Bello University, a Master of Science in Pharmacology from King’s College, University of London, and a Ph.D. in Molecular Genetics and Clinical Pharmacology from the University of London.